Bharat Biotech, Ocugen ink deal for supply of Covaxin to US
Hyderabad, Feb 3 Ocugen Inc and Bharat Biotech on Tuesday announced they have entered into a definitive agreement to co-develop, supply and commercialise Bharat Biotech’s Covaxin, an advanced stage whole-virion inactivated Covid-19 vaccine candidate, for the United States market. Ocugen,